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Introduction: Efforts to improve access to cancer care, including radiotherapy services in low 
and middle-income countries (LMICs) is challenging. Many radiotherapy initiatives in LMICs 
have failed to fully deliver on their promise because of multi-faceted barriers at the systems, 
organisational and patient levels, leading to significant wastage of scarce resources. Greater 
guidance on how to assess and build LMICs’ readiness for establishing sustainable 
radiotherapy services is needed to improve cancer care outcomes in LMICs. 
Aim: The ‘Access to Radiotherapy for Cancer treatment (ARC) Project’ aimed to provide 
practical guidance to LMICs on establishing safe and sustainable radiotherapy services. 
Methods: The mixed qualitative methods ARC Project involved a: systematic review; and two-
part qualitative study. The systematic review synthesised strategies adopted by LMICs to 
improve access to cancer treatment and palliative care. Semi-structured interviews undertaken 
with global radiotherapy experts explored perceived facilitators and barriers to establishing 
sustainable radiotherapy services in LMICs. The mid-point meta-inference of the systematic 
review and semi-structured interview data generated a draft list of requirements, which was 
circulated to global experts during the second part-of the qualitative study. The final meta-
inference was undertaken following the completion of the three studies. 
Findings: The systematic review identified that comparatively few studies have focused 
specifically on improving radiotherapy in LMICs, with no research evaluating effectiveness. The 
semi-structured interviews identified three key facilitators to establishing sustainable 
radiotherapy services in LMICs, namely: committing to a vision of improving cancer care; 
making it happen and sustaining a safe service; and leveraging off radiotherapy to strengthen 
integrated cancer care. The mid-point meta-inference generated 42 potential requirements, 
which were organised into four readiness domains: commitment (n=13); cooperation (n=7); 
capacity (n=17); and catalyst (n=5). The participant validation confirmed 37 of the generated 
requirements as relevant for inclusion in a radiotherapy service development readiness self-
assessment guide for use by LMICs. 
The end-point meta-inference of the ARC Project’s integrated data presented the ‘REadiness 
SElf-Assessment (RESEA) Guide’, with 120 questions that may help LMICs at macro and meso 
level to determine and create action plans to improve their readiness to establish radiotherapy 
services. 
Conclusions: The ARC Project has identified a complex combination of facilitators and barriers 
that influence the establishment of sustainable radiotherapy services in LMICs. It has developed 
a RESEA Guide to provide support for LMICs seeking to establish sustainable radiotherapy 
services. Further work is needed to evaluate the acceptability and feasibility of the RESEA 




ARC Project Access to Radiotherapy for Cancer treatment Project 
COREQ Consolidated criteria for Reporting Qualitative research 
GLOBOCAN  Global Cancer 
HICs High-Income Countries 
IAEA International Atomic Energy Agency 
ICTS Information and Communication Technologies 
LMICs Low and Middle-Income Countries 
NCDs Non-Communicable Diseases 
PRISMA Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses 
REASEA Guide REadiness SElf-Assessment Guide 
UICC Union for International Cancer Control 
WHO World Health Organisation 
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Glossary of Terms 
Access 
 
Access is a complex concept and at least five aspects require consideration: 
• accessibility is whether the services are effectively available for utilization; 
• affordability is about a system for financing health services, so people do not suffer 
financial hardship when using them; 
• appropriateness indicates services available ought to be relevant to the different 
parts of a population in terms of their health needs and material and cultural 
settings so as to ensure that the population would have access to positive health 
outcomes; 
• adequacy is whether there is an adequate and continued supply of available 
services; and 
• availability is whether services are available in the first place (Souliotis, 
Hasardzhiev & Agapidaki 2016). 
Barriers The obstacles that impede the effective implementation, sustainability and/or scale-up of 
cancer treatment and palliative care strategies. 
Cancer It is an abnormal cell divide in an uncontrolled biological mechanism and has the ability 
to spread into or invade other tissues (Cooper & Hausman 2000). 
Capacity The LMIC’s ability to translate commitment and cooperation to achieve sustainable 
results through effective and efficient management of the implementation process, a 
prepared workforce, maintenance, governance and information technology 
Catalyst The potential for LMICs to leverage from a radiotherapy service to develop an integrated 
cancer care service 
Cooperation The effective involvement of relevant international, national and local stakeholders in the 
planning, commissioning and operationalisation of a new radiotherapy service 
Commitment The LMIC’s willingness to put in place the necessary political, policy, funding and 
regulatory requirements to enable a radiotherapy service to be established 
Confirm When a current study reinforces the findings of the previous study 
Enhance When a current study further improve the findings of the previous study 
Facilitators Enabling factors that support effective implementation, sustainability and/or scale-up of 
cancer treatment and palliative care strategies. 
Radiotherapy The use of high energy rays in its different forms (X-rays, Gamma rays or particles) to 
cure or control cancer. Radiotherapy can either be external beam or brachytherapy. 
External beam radiotherapy is a non-invasive method of delivering targeted radiation to 
a tumour using equipment such as linear accelerator. Brachytherapy, which is also 
known as internal radiotherapy, involves implanting radioactive directly into or next to the 
tumour (Deeley 2013). 
Readiness The preparedness, willingness and response to develop, implement, sustain and/or 
scale-up improvement strategy (or change) (Holt et al. 2007; Weiner 2009). 
Implementation It is the process that puts strategies, plans and policies into action or effect to achieve 
desired goals (Saunders 2015). 
xvi 
 
Requirement It is any task, decision, procedure or necessary condition that supports the LMIC goal to 
establish a sustainable radiotherapy service. A requirement ideally needs to be satisfied 
by the LMIC for establishment a local radiotherapy service. 
Stakeholder Any individual, group or organisation that has an interest in developing, implementing 
and/or sustaining radiotherapy in low- and middle-income countries. They may be 
directly or indirectly involved with cancer radiotherapy (Bourne 2016; Fontaine, Haarman 
& Schmid 2006). 
Sustainability The ability or effort to maintain an improvement strategy (or change) that suits current 
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